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Background: miRNAs are critical post-transcriptional regulators of gene expression and key mediators of tumourigenesis.
miR-501-5p is newly identified to be involved in the tumor progression, but its biological role and mechanism remain
largely unknown. This study is aimed to study the role of miR-501-5p in the progression of gastric cancer.
Methods: Real-time PCR analysis was used to determine miR-501-5p expression in gastric cancer cell lines, clinical tissues
and 112 clinicopathologically characterized gastric cancer specimens. The role of miR-501-5p in maintaining gastric cancer
stem cell like phenotype was examined by tumor-sphere formation assay and expression of stem cell markers. Luciferase
reporter assay, cellular fractionation and western blot analysis were used to determined that miR-501-5p activated the
wnt/β-catenin signaling by directly targeting DKK1, NKD1 and GSK3β.
Results: Herein, our results revealed that miR-501-5p was markedly upregulated in gastric cancer cell lines and
clinical tissues. High miR-501-5p levels predicted poor overall survival in gastric cancer patients. Gain-of-function
and loss-of-function studies showed that ectopic expression of miR-501-5p enhanced the cancer stem cell-like
phenotype in gastric cancer cells. Notably,wnt/β-catenin signaling was hyperactivated in gastric cancer cells that
overexpress miR-501-5p, and mediated miR-501-5p-induced cancer stem cell-like phenotype. Furthermore, miR-501-5p
directly targeted and suppressed multiple repressors of the wnt/β-catenin signaling cascade, including DKK1, NKD1
and GSK3β. These results demonstrate that miR-501-5p maintains constitutively activated wnt/β-catenin signaling by
directly targeting DKK1, NKD1 and GSK3β, which promotes gastric cancer stem cell like phenotype.
Conclusions: Taken together, our findings reveal a new regulatory mechanism of miR-501-5p and suggest that miR-
501-5p might be a potential target in gastric cancer therapy.
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Gastric cancer (GC) is the fifth most common malig-
nancy and the third leading cause of cancer-related
death worldwide. It is estimated that 951,600 new GC
cases and 723,100 deaths occurred in 2012 [1]. In most
countries, survival from stomach cancer remained in the
narrow range of 25–30% [2]. Although therapeutic* Correspondence: dongmeifan9@sina.com
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therapy and chemotherapy, the prognosis for advanced
stage patients is still very poor [3, 4]. Recent studies have
revealed that gastric cancer stem cells constitute a reser-
voir of selfsustaining cells with the exclusive ability to
self-renew and cause tumor outgrowth [5].. Integral to
the CSC model is a subpopulation at the apex of the
hierarchy (usually comprising <5% of the cancer), re-
sponsible for the formation, maintenance, and continued
growth of the tumour [6]. However, the molecular
mechanisms for the maintenance of GC stem cell
phenotype remains largely unknown.le is distributed under the terms of the Creative Commons Attribution 4.0
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a key player in the regulation of tissue homeostasis,
organ size, tumorigenesis [7–9]. Upon activation, the
wnt signals will stabilize and finally lead to accumulation
of β-catenin. Activated β-catenin dissociates with E-
cadherin, dissembling the adherens and enters the nu-
cleus to turn on the expression of target genes, most of
which show invasion promotion functions [10]. Notably,
recent advances have shown that the wnt/β-catenin
signaling pathway is involved in the maintenance of the
GC stem cell population [11, 12]. It has been reported
that the pathway blocked by dickkopf WNT signaling
pathway inhibitor 1 (DKK-1), naked cuticle homolog 1
(NKD1) and glycogen synthase kinase 3 beta (GSK3β)
caused a robust reduction in the activity of wnt/β-catenin
signaling and self-renewing capacity of gastric cancer cells
[12–16]. Accordingly, the wnt/β-catenin signaling pathway
is considered as an important regulator in the mainten-
ance of CSC population, and better understanding of the
mechanisms that regulate wnt/β-catenin pathway may
provide new clues for more effective GC therapy.
MicroRNAs (miRNAs) are a class of highly conserved,
small noncoding RNAs that are approximately 22 nucle-
otides in length. Typically, miRNAs bind to the 3′-un-
translated regions (3′-UTRs) of mRNAs, guide the
formation of miRNA-mRNA-induced silencing com-
plexes and lead to the degradation or inhibit the transla-
tion of the targeted mRNAs [17, 18]. Bioinformatic
predictions indicate that miRNAs regulate more than
30 % of the protein-coding genes [19]. The dysregulation
of miRNA expression appears to be a general trait of GC
[20]. Thus, it is of particular interest to identify miRNAs
that might interfere with wnt/β-catenin signaling and
thereby lead to the self-renewal of GC stem cells.
In the present study, we sought to elucidate the the
effect of miR-501-5p on wnt/β-catenin signaling in GC,
as well as the related molecular mechanism by which
miR-501-5p affected wnt/β-catenin signaling. Our data
showed that miR-501-5p was upregulated in GC tissues
and correlated with a more aggressive phenotype of GC in
patients. miR-501-5p activates the wnt/β-catenin pathway
by directly targeting DKK1, NKD1 and GSK3β, and conse-
quently enhances stem cell-like phenotype of GC.
Methods
Tissues and cells
Fresh GC tissue samples from GC patients, and their
matched adjacent non-tumor gastric mucosal tissues
(>5 cm laterally from the edge of tumor region) were ob-
tained from the First Affiliated Hospital of Guangzhou
University of Chinese Medicine. The samples had been
clinically and histopathologically diagnosed according to
the World Health Organization criteria. Tumor and
non-cancerous tissues were confirmed histologically byhematoxylin and eosin staining. All samples were
collected from consenting individuals according to the
protocols approved by the Ethics Review Board at
Guangzhou University of Chinese Medicine. GC cell
lines SGC-7901, HGC-27, MGC-803, MKN-28 and
BGC-823 were routinely maintained in DMEM medium
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal
bovine serum (HyClone, Logan, UT).
Plasmids and oligonucleotides
The TOP/FOP Luciferase Reporting system was pur-
chased from lifeome (Oceanside, CA, USA). miR-501-5p
and miR-501-5p antagonist (antagomiR-501-5p, RiboBio,
Guangzhou, China) were used to overexpress or inhibit
miR-501-5p. The 3′UTRs of human DKK1, NKD1 and
GSK3β were generated by PCR amplification and sub-
cloned into the pGL3 vector plasmid (Promega, Madison,




















Cells were harvested in cell lysis buffer (Cell Signaling
Technology; Cat#: 9803) and heated for 5 min at 100 °C.
Equal quantities of denatured protein samples were re-
solved on 10% SDS-polyacrylamide gels and then trans-
ferred onto polyvinylidene difluoride membranes (Roche).
After blocking with 5% non-fat dry milk in Tris-buffered
saline/0.05% Tween 20 (TBST), the membrane was in-
cubated with a specific primary antibody followed by a
horseradish peroxidase-conjugated secondary antibody.
Proteins were visualized using ECL reagents (Pierce). The
antibodies used were as follows: anti-β-catenin, anti-DKK1,
anti-NKD1 and anti-GSK3β (Abcam, Cambridge, MA,
USA), and p-GSK3β (Ser9) (Cell Signaling Technology).
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anti–α-tubulin antibody (Sigma-Aldrich, St. Louis, MO,
USA) as the loading control.
MiRNA extraction and real-time quantitative PCR
Total miRNA from cultured cells and fresh surgical
gastric cancer tissues was extracted using a mirVana
miRNA Isolation Kit (Ambion, Austin, TX, USA) ac-
cording to the manufacturer’s instructions. We synthe-
sised cDNA from 10 ng total RNA using a TaqMan
miRNA reverse transcription kit (Applied Biosystems,
Foster City, CA, USA), and quantified the expression
levels of miR-501-5p using a miRNA-specific TaqMan
MiRNA Assay Kit (Applied Biosystems). miRNA expres-
sion was defined based on the threshold cycle (Ct), and
relative expression levels were calculated as 2-[(Ct of miR-
501-5p) – (Ct of U6)] after normalization with reference to
expression of U6 small nuclear RNA.
Sphere formation assays
1 × 103 cells were seeded in 6-well ultra low cluster
plates (Corning, NY) and about 10 cells were seeded in
24-well ultra low cluster plates (Corning, NY) for
15 days. Spheres were cultured in DMEM/F12 serum-
free medium (Invitrogen, Grand Island, NY) supple-
mented with 2% B27 (Invitrogen, Grand Island, NY),
20 ng/ml of EGF, and 20 ng/ml of bFGF (PeproTech,
Offenbach, Germany), 0.4% bovine serum albumin
(BSA) (Sigma, St. Louis, MO, USA), and 5 μg/ml insulin.
Luciferase assays
Cells (4 × 104) were seeded in triplicate in 24-well plates
and cultured for 24 h. Cells were transfected with
100 ng TOP/FOP reporter luciferase plasmid, or pGL3-
DKK1-3′UTR, pGL3-NKD1-3′UTRor pGL3-GSK3B-3′
UTR luciferase plasmids, plus 5 ng pRL-TK Renilla
plasmid (Promega) using Lipofectamine 2000 (Invitro-
gen) according to the manufacturer’s recommendation.Fig. 1 miR-501-5p is upregulated in human gastric cancer tissues and cell
became dramatically elevated in gastric cancer tissues by analyzing The Ca
(Normal, n = 41; gastric cancer, n = 395). P < 0.001, 2-tailed Student’s t-test. b
gastric epithelial cell (NGEC) and 5 cultured gastric cancer cell lines (b), and
(ANT) (c). Transcript levels were normalized by U6 expression. Error bars repLuciferase and Renilla signals were measured 36 h after
transfection using a Dual Luciferase Reporter Assay Kit
(Promega) according to the manufacturer’s protocol.
Statistical analyses
All statistical analyses were carried out using SPSS statis-
tical software (SPSS Inc., Chicago, IL, USA). The 2-tailed
Student’s t-test was used to evaluate the significance of the
differences between two groups of data in all pertinent ex-
periments; a P value <0.05 was considered significant.
Results
miR-501-5p is upregulated in human gastric cancer
tissues and cell lines
By analysis of the The Cancer Genome Atlas (TCGA)
Stomach adenocarcinoma miRNA sequencing data sets,
we found that miR-501-5p levels were significantly
upregulated in human gastric cancer tissues (n = 395)
compared with that in normal gastric tissues (n = 41)
(p < 0.001) (Fig. 1a). We further verified this result in
gastric cancer cell lines and paired tissues by real-
time PCR analysis. As shown in Fig. 1b and c, miR-
501-5p levels were differentially increased in 5 gastric
cancer cell lines than that in normal gastric epithelial
cell (NGEC), and in 10 gastric cancer tissues (T)
compared to that in the paired adjacent normal tis-
sues (ANT). Collectively, these results suggest that
miR-501-5p is upregulated and might be involved in
human gastric cancer progression.
High miR-501-5p predicts poor prognosis
We further assessed the clinical significance of miR-501-
5p expression levels in 112 gastric cancer tissues. As
shown in Fig. 2a, miR-501-5p expression was markedly
increased in 112 gastric cancer samples compared with
that in 12 non-cancerous gastric tissues. Importantly, pa-
tients with high miR-501-5p expression had a significant
poor overall survival compared to patients with lowlines. a miR-501-5p levels remained low in normal gastric tissues but
ncer Genome Atlas (TCGA) gastric cancer miRNA sequencing data sets
and c Real-time PCR analysis of miR-501-5p expression in normal
in 10 pairs of gastric cancer samples (T) and adjacent normal tissues
resent the mean ± s.d. of three independent experiments. *P < 0.05
Fig. 2 High miR-501-5p predicts poor prognosis. a Real-time PCR analysis of miR-501-5p expression in 112 freshly collected gastric cancer tissues
compared to that in 12 non-cancerous gastric tissues. Transcript levels were normalized to U6 expression. Boundaries of boxes represent lower
and upper quartiles, respectively. Lines within boxes and whiskers denote median and extremum, respectively. P < 0.001, 2-tailed Student’s t-test.
b Kaplan–Meier analysis of 5-year overall survival curves of patients with gastric cancer with high miR-501-5p expression (> median, n = 56) versus
low miR-501-5p expression (< median, n = 56) [hazard ratio (HR) = 2.413; 95% confidence interval (CI): 1.453–4.008]. P < 0.001, log-rank test
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95% CI = 1.453–4.008; Fig. 2b).miR-501-5p enhances the stem cell-like phenotype in
gastric cancer cells
It has been noted that aquisition of stem cell-like
phenotype of gastric cancer cells is crucial for the
malignance and high frequency of relapse [5]. We
then investigated the role of miR-501-5p upregulation
in the self-renewal ability of gastric cancer cells. Gas-
tric cancer cell lines MGC-803 and SGC-7901 were
engineered to overexpress or silence miR-501-5p by
transfection of miR-501-5p mimic or antagomiR-501-
5p (Additional file 1: Figure S1). Notably, overexpres-
sion of miR-501-5p robustly promoted gastric cancer
cells cultured in suspension to generate approximately
two-fold more tumor spheres and higher cell content,
compared with the spheres formed by control cells
until day 15 (Fig. 3a–c). Conversely, miR-501-5p-si-
lenced cells formed ~3-fold fewer spheres and lower
cell content, compared with control cells (Fig. 3a–c).
Moreover, flow cytometry assays revealed a higher
percentage of the side-population of cells in the miR-
501-5p overexpressing cells but a lower percentage in
the miR-501-5p-inhibited cells compared to control
(Additional file 2: Figure S2). In addition, overexpres-
sion of miR-501-5p increased, while downregulation
of miR-501-5p reduced the expression levels of differ-
ent stem cell regulators including CD44, CD133,
Bmi1, Nanog, MYC and SOX2 (Fig. 3d). Thus, our
results indicate that miR-501-5p promotes the stem
cell-like phenotype in gastric cancer.miR-501-5p activates wnt/β-catenin signaling pathway
Since wnt/β-catenin signaling is one of the most import-
ant pathways in maintaining stem cell phenotype and
frequently activated in gastric cancer, we then examined
the role of miR-501-5p in wnt/β-catenin signaling path-
way. As shown in Fig. 4a, we found that miR-501-5p
overexpression significantly increased, but silencing of
miR-501-5p reduced the TOP/FOP luciferase reporter
activity. In addition, cellular fractionation and western
blot analysis revealed that overexpression of miR-501-
5p increased nuclear accumulation of β-catenin, while
silencing of miR-501-5p reduced nuclear β-catenin ex-
pression (Fig. 4b). Moreover, real-time PCR analysis
revealed that miR-501-5p upregulated, but downregu-
lation of miR-501-5p repressed the expression levels
of the multiple wnt/β-catenin downstream genes
(Fig. 4c). Collectively, our results suggest that miR-
501-5p activates Wnt/β-catenin signaling pathway in
gastric cancer.
We further investigated the functional significance of
wnt/β-catenin signaling activation in miR-501-5p–medi-
ated self-renewal of gastric cancer cells by silencing β-
catenin or expressing TCF4-dn in miR-501-5p–overex-
pressing MGC-803 and SGC-7901 cells. As expected,
the stimulatory effect of miR-501-5p on TOP/FOP
luciferase reporter activity was impaired by silencing β-
catenin or expressing TCF4-dn (Fig. 4d). Moreover,
sphere formation assays indicated that silencing β-
catenin or expressing TCF4-dn abrogated the promotive
effects of miR-501-5p on self-renewal of gastric cancer
cells (Fig. 4e). Thus, these results reveal that activation
of wnt/β-catenin signaling is essential for miR-501-5p–
promoted stem cell like phenotype in gastric cancer.
Fig. 3 miR-501-5p enhances the stem cell-like phenotype in gastric cancer cells. a Representative micrographs of tumor spheres formed by indicated
cells. b Histograms showing the mean number of spheres formed by the indicated cells from different passages. c The fold change in the number of
cells per sphere on the indicated days. d Real-time PCR analysis revealed that miR-501-5p regulates the expression levels of numerous stem cell
regulators. The pseudocolors represent the intensity scale of expression in miR-501-5p vs. control-transfected cells or antagomiR-501-5p vs. control-
transfected cells generated by log2 transformation. Error bars represent the mean ± s.d. of three independent experiments. * P < 0.05
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catenin signaling pathway
Interestingly, using the publicly available algorithms
TargetScan and miRanda, we found that multiple repres-
sors of wnt/β-catenin signaling, i.e., DKK1, NKD1 and
GSK3B might be potential targets of miR-501-5p
(Fig. 5a). Western blot analysis revealed that overexpres-
sion of miR-501-5p markedly reduced the expression
levels of DKK1, NKD1 and GSK3β. In contrast, miR-
501-5p inhibition increased them, suggesting that miR-
501-5p negatively regulated these proteins (Fig. 5b).
Meanwhile, overexpression of miR-501-5p increased, but
inhibition of miR-501-5p repressed β-catenin expression
in gastric cancer cells (Fig. 5b). Luciferase assay showed
that miR-501-5p overexpression attenuated, while inhib-
ition of miR-501-5p elevated the reporter activities
driven by the 3′UTRs of DKK1, NKD1 and GSK3B tran-
scripts (Fig. 5c). However, ectopic expression of the
mutant miR-501-5p did not exhibit repressive effects on
the reporter activities driven by the 3′UTRs of these
transcripts (Fig. 5c). Moreover, microribonucleoprotein(miRNP) immunoprecipitation (IP) assay revealed a se-
lective association of miR-501-5p with DKK1, NKD1
and GSK3B, but not with GAPDH (Fig. 5d), further indi-
cating the specific effects of miR-501-5p on these tar-
gets. In addition, individual silencing of these targets
potently rescued the TOP/FOP luciferase reporter activ-
ity and self-renewal ability in miR-501-5p-inhibited cells
(Fig. 5e and f), demonstrating that DKK1, NKD1 and
GSK3β were functional effectors of miR-501-5p on regu-
lating wnt/β-catenin signaling activation and stem cell-
like phenotype in gastric cancer. Collectively, our results
suggest that miR-501-5p activates wnt/β-catenin signal-
ing to enhance stem cell-like phenotype in gastric cancer
by directly targeting DKK1, NKD1 and GSK3β.
Discussion
MicroRNAs have been demonstrated to negatively regu-
late target mRNAs in a sequence-specific manner, and
are key regulators in a wide variety of oncogenic pro-
cesses, such as cell proliferation, differentiation, invasion
and metastasis, functioning as either tumor suppressors
Fig. 4 miR-501-5p activates wnt/β-catenin signaling pathway. a TOP/FOP luciferase reporter assays in indicated cells. b Western blotting analysis
of β-catenin in nuclear fraction of cells. The nuclear protein p84 was used as the nuclear protein marker. MEK1/2 was used as the cytoplasmic
marker. c Real-time PCR analysis revealed that miR-501-5p regulates the expression levels of multiple wnt/β-catenin downstream genes in gastric
cancer cells. The pseudocolors represent the intensity scale of expression in miR-501-5p vs. control cells, or antagomiR-501-5p vs. control cells
generated by log2 transformation. d The stimulatory effect of miR-501-5p on TOP/FOP luciferase reporter activity was impaired by silencing β-
catenin or expressing TCF4-dn. e Sphere formation assays indicated that silencing β-catenin or expressing TCF4-dn abrogated the promotive
effects of miR-501-5p on self-renewal of gastric cancer cells. Error bars represent the mean ± s.d. of three independent experiments. *P < 0.05
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lying mechanism of miRNAs in tumor development may
provide valuable diagnostic and therapeutic strategies for
malignancy. Previous evidence has demonstrated that
miR-501-5p is overexpressed in human hepatocellular
carcinoma, and upregulation of miR-501-5p contributes
to cancer cell proliferation, migration, invasion and drug
resistance via different mechanisms [24]. Herein, com-
bining with the TCGA gastric cancer microRNA data set
analysis, our results revealed that miR-501-5p was mark-
edly upregulated in GC tissues compared with paired ad-
jacent normal tissues, and was significantly correlated
with a more aggressive phenotype of GC in patients.
Gastric cancer continues to be a highly lethal malig-
nancy, despite the use of multimodal treatment ap-
proaches. The CSC model has been proposed to explain
the high rate of relapse and subsequent resistance of
cancer to current systemic treatments [25]. CSCs havebeen identified in many solid malignancies, including
gastric cancer, and have significant clinical implications,
as targeting the CSC population may be essential in pre-
venting the recurrence and spread of a tumour [26, 27].
Herein, we found that miR-501-5p acted as a potent
CSC-promoting factor in GC. Overexpression of miR-
501-5p promoted the self-renewal of GC cells and up-
regulated the pluripotency associated markers, including
CD133, Bmi1, Nanog, MYC and Sox2. More importantly,
inhibition of miR-501-5p by antagomiR-501-5p potentially
reduced self-renewal of GC cells. Thus, our results suggest
that upregulation of miR-501-5p in GC is involved in the
malignant progression of GC, and propose that miR-501-
5p might be a potential therapeutic target for human
gastric cancer.
Accumulating evidence revealed that cancer stem cells
have higher metastatic potency by inducing Epithelial–
mesenchymal transition (EMT) [28]. Notably, Yoshida
Fig. 5 miR-501-5p directly targets multiple repressors of wnt/β-catenin signaling pathway. a Predicted miR-501-5p target sequence in 3'UTRs of DKK1,
NKD1 and GSK3B. The mutated miR-501-5p containing three altered nucleotides were indicated. b Western blots of DKK1, NKD1, GSK3β, p-GSK3β
(Ser9) and β-catenin expression. α-Tubulin served as the loading control. c Luciferase assay of pGL3-DKK1-3′UTR, pGL3-NKD1-3'UTR or pGL3-GSK3B-
3'UTR reporter in the miR-501-5p-, antagomiR-501-5p-, mutant miR-501-5p- and control-transfected MGC-803 cells. d MiRNP IP assay showing the
association between miR-501-5p and DKK1, NKD1 and GSK3B transcripts in MGC-803 cells. GAPDH served as the negative control. e Individual silencing
of DKK1, NKD1 and GSK3B potently rescued the TOP/FOP luciferase reporter activity and self-renewal ability in miR-501-5p-inhibited gastric cancer cells
(Fig. 5e and f), demonstrating that these genes were functional effectors of miR-501-5p on regulating wnt/β-catenin signaling activation and stem cell-
like phenotype in gastric cancer. Error bars represent the mean ± s.d. of three independent experiments. * P < 0.05
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ical Wnt activation play an important role in the hetero-
geneous cancer stem cell population at the invasive area
by regulating CD44 and c-Myc [29]. Herein, we found
that miR-501-5p increased the stemness in gastric
cancer by activating the Wnt/β-catenin signaling and in-
creasing the expression of CD44 and c-Myc. Thus, miR-
501-5p might contribute to gastric cancer metastasis,
and this hypothesis remains to be examined. For ex-
ample, does miR-501-5p induce EMT; is miR-501-5p
increased at the invasive edge of gastric cancer tissues;does miR-501-5p regulate the heterogeneous cancer
stem cell population; these questions remain to be an-
swer. Moreover, it was reported that Wnt activation
could be induced by micro-environmental stress [29].
Therefore, it would be interesting to investigate whether
micro-environmental stress is responsible for miR-501-
5p upregulation in gastric cancer.
Several signaling pathways, including the wnt/β-ca-
tenin, Notch, and PI3K/Akt pathways, have been found
to be aberrantly activated and play vital roles in the de-
velopment and progression of gastric cancer [11, 30, 31]
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signaling in gastric cancer development and progression
have been well documented. TCF4 and coactivator β-
catenin are two key downstream effectors of the wnt/β-
catenin signaling pathway, and considered as potent
oncogenes in tumor progression [7]. Notably, unlike
in other cancer types, the mutations in β-catenin are
rare, but the expression and/or nuclear localization of
β-catenin is often abnormal in gastric cancer, indicat-
ing a constitutive activation of Wnt/β-catenin signal-
ing [7, 11, 12]. However, how cancer cells evade the
negative regulation by wnt/β-catenin signaling cascade,
leading to constitutively activated β-catenin/TCF remains
unclear. Herein, we demonstrated that miR-501-5p was
substantially overexpressed in gastric cancer and induced
hyper-activation of β-catenin/TCF via directly targeting
DKK1, NKD1 and GSK3β. Therefore, our findings not
only suggest activation of Wnt/β-catenin pathway contrib-
utes to the malignant behavior of gastric cancer, but also
reveal a novel mechanism for activation of wnt/β-catenin
pathway involving miR-501-5p in gastric cancer.
It was reported that GSK-3β exhibited both oncogenic
and tumor-suppressive roles in the context of different
cancer types. For example, Tang et al. found that loss of
GSK-3β expression activated β-Catenin to upregulate the
expression of miR-183-96-182 cluster, leading to prolifera-
tion and migration of gastric cancer [32]. In contrast, in-
hibition of GSK3β compromises the survival, proliferation
and invasion of glioblastoma cells [33]. Herein, we found
that miR-501-5p repressed GSK3β to activate Wnt/β-Ca-
tenin pathway and enhance gastric cancer stem cell
phenotype, further suggesting a tumor-repressive role of
GSK3β in gastric cancer. Moreover, the role of miR-501-
5p in glioblastoma remains to be further examined in
future. Appropriate reference and discussion have been
incorporated into revised manuscript.Conclusions
In conclusion, our study has revealed that miR-501-5p
upregulation plays an important role in gastric cancer
progression and miR-501-5p is a critical activator of Wnt/
β-catenin signaling by targeting DKK1, NKD1 and GSK3β.
Understanding the precise role of miR-501-5p in gastric
cancer pathogenesis and in the wnt/β-catenin signaling
pathway promises to increase our knowledge of the bio-
logical basis of cancer development and may also facilitate
the development of new therapeutic strategies against
gastric cancer.Additional files
Additional file 1: Figure S1. Real-time PCR analysis of miR-501-5p in
miR-501-5p-overexpressing, miR-501-5p-silenced and control MGC-803 andSGC-7901 cell lines. Transcript levels were normalized to U6 expression.
(TIF 97 kb)
Additional file 2: Figure S2. Hoechst 33342 dye exclusion assay
showing that overexpressing miR-501-5p promoted, whereas inhibition
of miR-501-5p attenuated, the side-population cells in gastric cancer cells.
(TIF 193 kb)
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